Pre-existing conditions and non-obstetric disease cause more maternal deaths in the UK than obstetric complications

Pregnant women should receive the same investigations and treatments as non-pregnant patients with avoidance of harm to the foetus wherever possible

Physiological Changes

SystemNormal pregnancyConsider pathology
Cardiovasculara fall in BP before week 20 (rises back up)

Increased HR, SV & CO
persistent BP >140/90 might indicate Pre-eclampsia
RespiratoryCompensated respiratory alkalosis

No change in PEFR or VC

Altered chemoreceptor sensitivity + consumption RR + 10%
Serum bicarb <18 mmol/L

Decreased PEFR

RR <20/min
Renal renal perfusion, GFR, protein excretion
urea, creatinine

bladder capacity decreases

RAAS increased in 1st trimester - smooth muscle dilation

increased risk of UTIs
Creatinine >85 mol/L (eGRF not valid in pregnancy)
GIlower oesophageal pressure

altered appetite

decrease in motility

water reabsorption

constipation, nausea, heartburn
HaematologyDecreased clot lysis (reduced protein S, APC resistance, increased plasminogen activator inhibitors)
Increased clot formation (increased factors I, V, VII, VIII, IX, X, XII)

Radiology

If the uterus is positioned outside the imagining field of view, the radiation dose to the foetus is minimal. Exposure from the following is well below the threshold of risk to the foetus:

  • Plain radiograph: chest, extremities, spine
  • CT: head, chest (but consider radiation to maternal breast in pregnancy

Ultrasound and MRI are generally preferred when imaging abdomen

Drugs

Should always be a balance of risk - drugs different again in lactation

Considered safeContraindicated
PenicillinsTetracycline/Doxycycline
MacrolidesCiprofloxacin
Low molecular weight heparinTrimethoprim (1st trimester)
AspirinNSADs (3rd trimester)
LabetalolACEi
NifedipineARA
AdenosineMycophenolate
PrednisoloneWarfarin
Treatment for asthma: Salbutamol, ipratropium, aminophylline, leukotriene antagonistsLive vaccines (MMR, BCG, varicella)